News

Mobile MTM developer receives NIH grant

BY Alaric DeArment

CHICAGO – A company developing mobile medication therapy management technology got a big boost from the federal government.

Leap of Faith Technologies announced that it had received a grant worth more than $1 million from the National Cancer Institute, part of the National Institutes of Health, to develop its eMedonline software-as-service mHealth mobile-health platform for iPhone and Android devices. The company said the platform improves medication adherence, monitors outcomes and provides opportunities for drug surveillance and research data mining, saying the platform had demonstrated medication adherence levels of 98%, along with “significant” improvements in patient self-efficacy in NIH- and industry-funded clinical trials.

The company hopes to use the grant to bring its technology to the marketplace, and an industry partner will match the NIH grant to connect the platform to an electronic health record system.

Leap of Faith founder and chief science officer Barbara Rapchak said, “eMedonline represents the convergence of mobile technology, clinical and behavioral science and validated clinical outcomes in a mHealth platform that facilitates coordinated care and also supports meaningful use.” 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Dr. Reddy’s launches antibiotic products

BY Alaric DeArment

HYDERABAD, India — Drug maker Dr. Reddy’s Labs has launched a generic antibiotic drug, the company said Thursday.

The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension. The tablets are being launched in the 500-mg and 875-mg strengths, while the capsules are in the 250-mg and 500-mg strengths, and the oral suspension is in the 125-mg-, 200-mg-, 250-mg- and 400-mg-per-5-mL strengths.

The drug is a generic version of GlaxoSmithKline’s Amoxil. For the 12-month period ended in June, branded and generic versions of the drug had sales of $22.2 million for the tablets, $67.2 million for the capsules and $89.5 million for the oral suspension, according to IMS Health.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Educational series from SisterLove, Merck shows ‘everyone has a story’

BY Allison Cerra

ATLANTA — Atlanta-based reproductive and sexual health organization SisterLove and drug maker Merck have collaborated to create a mini-documentary and educational HIV/AIDS treatment and care resource.

"Everyone Has a Story," launched last March, is an educational capacity and skills-building initiative for healthcare professionals and HIV-positive women. EHAS uses video-based storytelling to empower individuals to address stigma, navigate disclosure, build strong relationships with providers and live healthier lives. EHAS includes a DVD with five topical vignettes, workshop materials (preparation and facilitator’s guide, slide deck, group activity worksheets) and a treatment adherence journal.

To learn more about the program and HIV, view the EHAS videos here.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?